Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques
暂无分享,去创建一个
[1] T. Patterson,et al. Current concepts in Cryptococcosis , 1989, European Journal of Clinical Microbiology and Infectious Diseases.
[2] M. Ghannoum,et al. In Vitro Activities of Voriconazole, Fluconazole, and Itraconazole against 566 Clinical Isolates of Cryptococcus neoformans from the United States and Africa , 1999, Antimicrobial Agents and Chemotherapy.
[3] B. Wanke,et al. Cryptococcus neoformans var. gattii--evidence for a natural habitat related to decaying wood in a pottery tree hollow. , 1998, Medical mycology.
[4] J. Martínez-Suárez,et al. Standardization of antifungal susceptibility testing and clinical relevance. , 1998, Medical mycology.
[5] F. Dromer,et al. Antifungal drug resistance in pathogenic fungi. , 1998, Medical mycology.
[6] J. Perfect,et al. Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches. , 1997, Drugs.
[7] S. Franzot,et al. In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs , 1996, Antimicrobial agents and chemotherapy.
[8] T. G. Mitchell,et al. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans , 1995, Clinical microbiology reviews.
[9] D. Dunt,et al. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] A. Tunkel,et al. Therapy of fungal meningitis. , 1995, Clinical neuropharmacology.
[11] T. Sorrell,et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] A. Casadevall,et al. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole , 1993, Antimicrobial Agents and Chemotherapy.
[13] M. Ghannoum,et al. Susceptibility testing of Cryptococcus neoformans: a microdilution technique , 1992, Journal of clinical microbiology.
[14] M. Pfaller,et al. Multicenter evaluation of four methods of yeast inoculum preparation , 1988, Journal of clinical microbiology.
[15] G. Wormser,et al. In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome. , 1988, Archives of pathology & laboratory medicine.
[16] Á. Restrepo,et al. Growth of Paracoccidioides brasiliensis yeast phase in a chemically defined culture medium , 1980, Journal of clinical microbiology.
[17] W. Merz,et al. Incidence of polyene-resistant yeasts recovered from clinical specimens , 1980, Antimicrobial Agents and Chemotherapy.